Skip to content
10-Q

Quarterly Report

GENOCEA BIOSCIENCES, INC.

0001457612-22-000054

← back to feed
Filed
May 5, 2022 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Apr 29, 2022 58.78M sh
Shares Diluted Q1 2022 · Mar 31, 2022 71.12M sh
Shares Diluted Q1 2022 · Mar 31, 2021 74.22M sh
Capex Q1 2022 · Mar 31, 2022 $961K
Capex Q1 2022 · Mar 31, 2021 $1.11M
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$15.21M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$12.39M
Long Term Debt Q1 2022 · Mar 31, 2022 $2.95M
Long Term Debt Q1 2022 · Dec 31, 2021 $4.15M
Short Term Debt Q1 2022 · Mar 31, 2022 $4.7M
Short Term Debt Q1 2022 · Dec 31, 2021 $4.64M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $20.14M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $37.15M
Stockholders Equity Q1 2022 · Mar 31, 2022 $12.39M
Stockholders Equity Q1 2022 · Dec 31, 2021 $27.08M
Stockholders Equity Q1 2022 · Mar 31, 2021 $1.76M
Stockholders Equity Q1 2022 · Dec 31, 2020 $8.98M
Current Liabilities Q1 2022 · Mar 31, 2022 $18.03M
Current Liabilities Q1 2022 · Dec 31, 2021 $18.68M
Total Liabilities Q1 2022 · Mar 31, 2022 $26.4M
Total Liabilities Q1 2022 · Dec 31, 2021 $28.89M
Current Assets Q1 2022 · Mar 31, 2022 $24.41M
Current Assets Q1 2022 · Dec 31, 2021 $41.82M
Total Assets Q1 2022 · Mar 31, 2022 $38.79M
Total Assets Q1 2022 · Dec 31, 2021 $55.97M
Eps Diluted Q1 2022 · Mar 31, 2022 −$0.22
Eps Diluted Q1 2022 · Mar 31, 2021 −$0.17
Eps Basic Q1 2022 · Mar 31, 2022 −$0.22
Eps Basic Q1 2022 · Mar 31, 2021 −$0.18
Sga Expense Q1 2022 · Mar 31, 2022 $3.6M
Sga Expense Q1 2022 · Mar 31, 2021 $3.67M
Rd Expense Q1 2022 · Mar 31, 2022 $12.44M
Rd Expense Q1 2022 · Mar 31, 2021 $8.75M
Net Income Q1 2022 · Mar 31, 2022 −$15.98M
Net Income Q1 2022 · Mar 31, 2021 −$11.98M
Operating Income Q1 2022 · Mar 31, 2022 −$15.77M
Operating Income Q1 2022 · Mar 31, 2021 −$12.42M